Insurance Coverage for Coronary Calcium CT Scan

Primary Coverage Indications

The American College of Cardiology recommends coronary artery calcium (CAC) measurement for asymptomatic adults at intermediate risk (10-20% 10-year risk) of coronary artery disease, as it is considered appropriate and generally covered by insurance for cardiovascular risk assessment 1, 2
The American College of Cardiology also considers CAC measurement reasonable for low-to-intermediate risk patients (6-10% 10-year risk), though coverage may vary by insurer 1, 3
Low-risk patients with a family history of premature coronary heart disease may be covered for CAC scoring, as it is considered appropriate for this specific subset 3

CAC scoring provides incremental prognostic value beyond traditional risk factors, particularly in the intermediate-risk population, where reclassification of risk can significantly impact treatment decisions 4
The 2010 American College of Cardiology Foundation/American Heart Association guidelines gave a Class IIa recommendation (benefit >> risk) for CAC measurement in asymptomatic adults at intermediate risk 1
Insurance coverage typically aligns with clinical appropriateness criteria, focusing on populations where test results would likely change management 5, 2

Low-risk patients (<6% 10-year risk) without a family history of premature coronary heart disease should not undergo CAC measurement, as it is generally not covered by insurance 1, 3
Repeat coronary calcium testing is typically considered inappropriate and not covered 3
Screening asymptomatic patients using coronary CT angiography (as opposed to calcium scoring) is considered inappropriate and not covered 3

Diabetic patients may have expanded coverage indications due to their elevated baseline cardiovascular risk 5
Younger patients (age 40-45) with cardiac risk factors may benefit from CAC scoring despite low calculated 10-year risk, as age heavily influences risk calculations 4

CAC scores are typically reported using either the Agatston scoring system or visual assessment methods (none, mild, moderate, heavy/severe) 6, 7
The Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology recommend reporting CAC in all patients regardless of scan indication 7
CAC scoring radiation dose is relatively low (typically 1.5 mSv), comparable to mammography, which may factor into coverage decisions 1
Insurance coverage generally follows the "power of zero" concept - absence of coronary calcification (score of zero) indicates very low cardiovascular risk and may influence subsequent testing coverage 5

Coverage policies may vary between insurance providers and plans, so verification with specific insurers is recommended before proceeding with testing 2, 3

The American College of Cardiology/American Heart Association gives CT coronary artery calcium (CAC) scoring a Class IIa recommendation (Level of Evidence: B-NR) for asymptomatic adults aged 40-75 years at intermediate risk (7.5% to <20% 10-year ASCVD risk) or selected borderline risk patients (5% to <7.5% 10-year ASCVD risk) when treatment decisions remain uncertain 8
CAC scoring is reasonable as a guide for shared decision-making when decisions about preventive interventions (particularly statin therapy) are uncertain in intermediate risk patients (7.5% to <20% 10-year ASCVD risk) 8, 9
Selection criteria for borderline risk patients include presence of risk-enhancing factors such as family history of premature CHD, persistently elevated LDL-C, metabolic syndrome, chronic kidney disease, or inflammatory diseases 10

The 2019 ACC/AHA guidelines provide specific guidance on how to use CAC results, including withholding statin therapy in patients with a CAC score of 0 and reassessing in 5-10 years, unless higher-risk conditions are present 8
It is reasonable to initiate statin therapy for patients ≥55 years of age with a CAC score of 1-99 8
It is reasonable to initiate statin therapy for patients with a CAC score ≥100 or ≥75th Percentile 8

CAC scoring is generally not recommended for men <40 years or women <50 years due to low prevalence of detectable calcium and radiation exposure concerns 11, 12, 13
The radiation dose from CAC scoring is relatively low (0.9-1.5 mSv), comparable to 1-2 mammograms 11, 12
CAC = 0 does NOT exclude non-calcified plaque or obstructive coronary disease, and 7-38% of symptomatic patients with CAC = 0 have obstructive disease 9

The American College of Cardiology recommends CAC scoring for asymptomatic adults at intermediate cardiovascular risk (10-20% 10-year risk) when decisions about preventive therapy remain uncertain, and for low-risk patients with a family history of premature coronary heart disease 14, 15
Intermediate risk is defined as 10-20% 10-year risk, with individual exceptions for a broadened range of 6-20% in younger men and women with high relative risk but low absolute risk 14, 15
Patients with CAC scores >100 or ≥75th percentile for age and sex should be reclassified to high risk and treated more aggressively 14
In a cohort of 14,169 low-risk patients with family history of CAD, CAC >100 showed 2.2 times higher all-cause mortality, 4.3 times higher cardiovascular mortality, and 10.4 times higher coronary heart disease risk compared to zero calcium score 16

The American College of Cardiology states that screening asymptomatic patients using coronary CT angiography (as opposed to calcium scoring alone) is inappropriate 14, 15
The US Preventive Services Task Force recommends against routine screening in adults at low risk for CHD events (Grade D recommendation) 17
Repeat coronary calcium testing is considered inappropriate 14, 15

The American College of Cardiology recommends CT angiography for patients with reduced left ventricular ejection fraction and low or intermediate pretest CAD probability 14, 15
CT angiography is appropriate for patients undergoing noncoronary cardiac surgery (valve replacement, atrial septal defect closure) with intermediate pretest CAD risk 14, 15
No appropriate indications exist for coronary CT angiography as part of preoperative evaluation for noncardiac surgery 14